Home・Список акций・Cytek Biosciences Inc

Cytek Biosciences Inc

Закрыт

СекторЗдравоохранение

4.22 1.44

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

4.09

Макс.

4.22

Ключевые показатели
By Trading Economics
Доход	25M -19M
Продажи	-18M 44M
Прибыль на акцию	-0.1
Рентабельность продаж	-42.746
Сотрудники	678
EBITDA	-14M -14M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+33.65% upside

Дивиденды
By Acuity
Следующий отчет о доходах	4 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-45M 557M
Предыдущая цена открытия	2.78
Предыдущая цена закрытия	4.22

Новостные настроения

By Acuity

50%

151 / 340 Рейтинг в Healthcare

Cytek Biosciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 авг. 2026 г., 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 авг. 2026 г., 20:02 UTC

News

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 авг. 2026 г., 22:02 UTC

News

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 авг. 2026 г., 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 авг. 2026 г., 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 июл. 2026 г., 19:26 UTC

Correlated Moves

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 июл. 2026 г., 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 июл. 2026 г., 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 июл. 2026 г., 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 июл. 2026 г., 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 июл. 2026 г., 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 июл. 2026 г., 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.

Сравнение c конкурентами

Изменение цены

Cytek Biosciences Inc Прогноз

Целевая цена

By TipRanks

33.65% рост

Прогноз на 12 месяцев

Средняя 5.56 USD 33.65%

Максимум 7.5 USD

Минимум 4.75 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Cytek Biosciences Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

4 ratings

Покупка

Удержание

Продажа

Основано на мнении 4 аналитиков, присваивавших рейтинги акциям Cytek Biosciences Inc – Данные за последние 3 месяца.

Настроения

By Acuity

151 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.